Related references
Note: Only part of the references are listed.Benefits and limitations of genome-wide association studies
Vivian Tam et al.
NATURE REVIEWS GENETICS (2019)
Towards precision medicine: interrogating the human genome to identify drug pathways associated with potentially functional, population-differentiated polymorphisms
Maulana Bachtiar et al.
PHARMACOGENOMICS JOURNAL (2019)
Association of PPARG Gene Polymorphisms Pro12Ala with Type 2 Diabetes Mellitus: A Meta-analysis
Junyan Li et al.
CURRENT DIABETES REVIEWS (2019)
The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development
Fan Hong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps
Anubha Mahajan et al.
NATURE GENETICS (2018)
Genetic Approaches to the Study of Gene Variants and Their Impact on the Pathophysiology of Type 2 Diabetes
Monica Szabo et al.
BIOCHEMICAL GENETICS (2018)
A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog
Joannella Morales et al.
GENOME BIOLOGY (2018)
Human Genetics of Obesity and Type 2 Diabetes Mellitus Past, Present, and Future
Erik Ingelsson et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
Association of Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor gamma 2 (PPARγ2) Gene with Type 2 Diabetes Mellitus in Ethnic Kashmiri Population
Misbah Majid et al.
BIOCHEMICAL GENETICS (2017)
Interaction between peroxisome proliferator-activated receptor gamma polymorphism and obesity on type 2 diabetes in a Chinese Han population
Xiaohui Lv et al.
DIABETOLOGY & METABOLIC SYNDROME (2017)
Implications of critical PPARγ2, ADIPOQ and FTO gene polymorphisms in type 2 diabetes and obesity-mediated susceptibility to type 2 diabetes in an Indian population
Nagaraja M. Phani et al.
MOLECULAR GENETICS AND GENOMICS (2016)
Role of PPARG (Pro12Ala) in Malaysian type 2 diabetes mellitus patients
Darishiani Paramasivam et al.
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES (2016)
Association of variable rs1801282 locus of PPARG2 gene with diabetic nephropathy
D. Sh. Avzaletdinova et al.
RUSSIAN JOURNAL OF GENETICS (2016)
Prevalence of PPAR-γ2 (rs1801282), RETN (rs3745367) and ADIPOQ (rs2241766) SNP markers in the Bangladeshi type 2 diabetic population
Razwa Saleh et al.
META GENE (2016)
Dominance Genetic Variation Contributes Little to the Missing Heritability for Human Complex Traits
Zhihong Zhu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
Proliferator-activated receptor gamma Pro12Ala interacts with the insulin receptor substrate 1 Gly972Arg and increase the risk of insulin resistance and diabetes in the mixed ancestry population from South Africa
Zelda Vergotine et al.
BMC GENETICS (2014)
Adiponectin and peroxisome proliferator-activated receptor-γ gene polymorphisms and gene-gene interactions with type 2 diabetes
Enling Ye et al.
LIFE SCIENCES (2014)
Role of peroxisome proliferator-activated receptor gamma gene polymorphisms in type 2 diabetes mellitus patients of West Bengal, India
Arup Kumar Pattanayak et al.
JOURNAL OF DIABETES INVESTIGATION (2014)
Association of IRS1, CAPN10, and PPARG gene polymorphisms with type 2 diabetes mellitus in the high-risk population of Hyderabad, India
Uma Jyothi Kommoju et al.
JOURNAL OF DIABETES (2014)
PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China
Qi Pei et al.
ACTA PHARMACOLOGICA SINICA (2013)
The genetics of type 2 diabetes and its clinical relevance
A. Pal et al.
CLINICAL GENETICS (2013)
The Association between the Pro12Ala Variant in the PPARγ2 Gene and Type 2 Diabetes Mellitus and Obesity in a Chinese Population
Xia Wang et al.
PLOS ONE (2013)
Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARγ, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs
N. Mtiraoui et al.
DIABETES & METABOLISM (2012)
Association of the PPARG Pro12Ala polymorphism with type 2 diabetes and incident coronary heart disease in a Hong Kong Chinese population
Janice S. K. Ho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Association of MTHFR and PPARγ2 gene polymorphisms in relation to type 2 diabetes mellitus cases among north Indian population
Syed Tasleem Raza et al.
GENE (2012)
A Replication Study of the IRS1, CAPN10, TCF7L2, and PPARG Gene Polymorphisms Associated with Type 2 Diabetes in Two Different Populations of Mexico
Laura E. Martinez-Gomez et al.
ANNALS OF HUMAN GENETICS (2011)
Genetic Variants in Peroxisome Proliferator-Activated Receptor-γ and Retinoid X Receptor-α Gene and Type 2 Diabetes Risk: A Case-Control Study of a Chinese Han Population
Ying Lu et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) Pro12Ala in the Iranian population: Relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes
Fatemeh Namvaran et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
The Association Between the Peroxisome Proliferator-Activated Receptor-γ2 (PPARG2) Pro12Ala Gene Variant and Type 2 Diabetes Mellitus: A HuGE Review and Meta-Analysis
Hebe N. Gouda et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
The Ala allele in the PPAR-γ2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects
Grazielle Vilas Boas Huguenin et al.
BRITISH JOURNAL OF NUTRITION (2010)
The PPAR gamma Pro12Ala variant is associated with insulin sensitivity in Russian normoglycaemic and type 2 diabetic subjects
Dimitry A. Chistiakov et al.
DIABETES & VASCULAR DISEASE RESEARCH (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor
Dharambir Kaur Sanghera et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Evidence for an association with type 2 diabetes mellitus at the PPARG locus in a South Indian population
Karani S. Vimaleswaran et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
Systematic Reviews: The Good, the Bad, and the Ugly
Yuhong Yuan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Characterization of a Novel Polymorphism in PPARG Regulatory Region Associated with Type 2 Diabetes and Diabetic Retinopathy in Italy
Valerio Costa et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2009)
Finding the missing heritability of complex diseases
Teri A. Manolio et al.
NATURE (2009)
Polymorphism of Pro12Ala in the Peroxisome Proliferator-Activated Receptor γ2 Gene in Iranian Diabetic and Obese Subjects
Hassan Mirzaei et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2009)
Effect of ENPP1/PC-1-K121Q and PPARγ-Pro12Ala polymorphisms on the genetic susceptibility to T2D in the Tunisian population
R. Bouhaha et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes
Eleftheria Zeggini et al.
NATURE GENETICS (2008)
Lack of association between the Pro12Ala polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in the Qatari consanguineous population
Ramin Badii et al.
ACTA DIABETOLOGICA (2008)
Genetic polymorphism of peroxisome proliferator-activated receptor-γ2 Pro12Ala on ethnic susceptibility to diabetes in Uygur, Kazak and Han subjects
Lin-Lin Li et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Association of the peroxisome proliferator-activated receptor-γ2 Pro12Ala but not the C1431T gene variants with lower body mass index in Type 2 diabetes
M. Ben Hadj Mohamed et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2007)
The relationship of the peroxisome proliferator-activated receptor-gamma 2 exon 2 and exon 6 gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy
M. Erdogan et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Paul R. Burton et al.
NATURE (2007)
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Laura J. Scott et al.
SCIENCE (2007)
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Richa Saxena et al.
SCIENCE (2007)
Heterogeneous effect of peroxisome proliferator-activated receptor γ2 Ala12 variant on type 2 diabetes risk
Ornella Ludovico et al.
OBESITY (2007)
Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma 2 (PPAR gamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population
Reza Meshkani et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
Role of genetic polymorphism peroxisome proliferator-activated receptor-γ2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects
V Radha et al.
DIABETES CARE (2006)
Examining the relationships between the Pro12Ala variant in PPARG and Type 2 diabetes-related traits in UK samples
E Zeggini et al.
DIABETIC MEDICINE (2005)
Association between Pro12Ala polymorphism of the PPAR-γ2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus
V Tavares et al.
DIABETES OBESITY & METABOLISM (2005)
Genetic polymorphisms in peroxisome proliferator-activated receptor γ are associated with Type 2 diabetes mellitus and obesity in the Korean population
MK Moon et al.
DIABETIC MEDICINE (2005)
Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetes
SK Hansen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
A method for meta-analysis of molecular association studies
A Thakkinstian et al.
STATISTICS IN MEDICINE (2005)
The peroxisome proliferator activated receptorγ2 (PPARγ2) Pro12Ala variant:: lack of association with type 2 diabetes in obese and non obese Tunisian patients
KZ Bouassida et al.
DIABETES & METABOLISM (2005)
Implication of the Pro 12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population -: art. no. 11
M Ghoussaini et al.
BMC MEDICAL GENETICS (2005)
Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes
ASF Doney et al.
DIABETOLOGIA (2004)
Association of Pro12Ala polymorphism of PPARγ gene with insulin resistance and related diseases
M Horiki et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2004)
Prospective study of the association between the proline to aline codon 12 polymorphism in the PPARγ gene and type 2 diabetes
A Memisoglu et al.
DIABETES CARE (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
A functional variant in the peroxisome proliferator-activated receptor γ2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians
YL Muller et al.
DIABETES (2003)
Pro 12Ala of the peroxisome proliferator-activated receptor-γ2 gene is associated with lower serum insulin levels in nonobese African Americans -: The Atherosclerosis Risk in Communities study
WHL Kao et al.
DIABETES (2003)
The Pro12Ala polymorphism of PPAR gamma 2 gene and susceptibility to type 2 diabetes mellitus in a Polish population
MT Malecki et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2003)
Genetics of obesity and type 2 diabetes -: Tracking pathogenic traits during the predisease period
P Bougnères
DIABETES (2002)
Differential effect of PPARγ2 variants in the development of type 2 diabetes between native Japanese and Japanese Americans
M Nemoto et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2002)
Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus
I Simon et al.
HORMONE RESEARCH (2002)
Approaches to heterogeneity in meta-analysis
DB Petitti
STATISTICS IN MEDICINE (2001)
The Pro12→Ala substitution in PPAR-γ is associated with resistance to development of diabetes in the general population -: Possible involvement in impairment of insulin secretion in individuals with type 2 diabetes
H Mori et al.
DIABETES (2001)
The peroxisome poliferator-activated receptor-γ2 Pro12Ala variant -: Association with type 2 diabetes and trait differences
JA Douglas et al.
DIABETES (2001)
Association between the P12A and cl431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes
D Evans et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2001)
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
S Duval et al.
BIOMETRICS (2000)
The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes
K Clement et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
The Pro12Ala polymorphism in PPAR γ2 may confer resistance to type 2 diabetes
K Hara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-γ 2 on thiazolidinedione-induced adipogenesis
J Masugi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus
A Meirhaeghe et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Share Paper
